Chromogranin A is an aging risk factor
嗜铬粒蛋白 A 是衰老的危险因素
基本信息
- 批准号:10667265
- 负责人:
- 金额:$ 22.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adipose tissueAdrenergic ReceptorAgeAgingAlzheimer&aposs disease brainAlzheimer&aposs disease patientAnti-Inflammatory AgentsAntidiabetic DrugsAntihypertensive AgentsAntioxidantsAutoimmune DiseasesAutophagocytosisBacterial DNABiochemicalBiological ProcessBloodBlood GlucoseBlood PressureBlood VesselsCardiacCatecholaminesCellsCessation of lifeCharacteristicsCholesterolChromogranin AChronicClinicalCollaborationsCommunicationCoupledDataDense Core VesicleDevelopmentDiabetes MellitusDiseaseEatingElderlyEndocrineEnergy MetabolismExhibitsExtravasationFatty AcidsFemaleFutureGene ExpressionGene Expression ProfilingGenesGoalsGrowthHealthHeartHeart failureHormonesHypertensionImmunoglobulin DomainInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInsulinInsulin ResistanceIntestinal permeabilityKidney FailureKnock-outKnockout MiceLifeLipoproteinsLiverLiver DysfunctionLongevityLongitudinal StudiesMaintenanceMalignant NeoplasmsMediatingMessenger RNAMetabolismMitochondriaModelingMusMuscleNeuroendocrine CellNeuronsNeurosecretory SystemsNeurotransmittersNorepinephrineOrganPathogenicityPathway interactionsPatientsPeptidesPhysiologicalPhysiologyPlasmaProcessProteinsProteolytic ProcessingPublishingRegulationReportingResearchRespirationRheumatoid ArthritisRisk FactorsRoleSET DomainSignal PathwaySignal TransductionTestingTissue SampleTissuesTranscriptTriglyceridesTumor Suppressor ProteinsWild Type Mouseadipokinesadiponectinage groupage relatedagedblood pressure elevationcohortdiabeticexperimental studyhuman old age (65+)hypertensiveimprovedinsulin sensitivitylipid metabolismlipoprotein lipasemalemature animalmouse modelnervous system disorderoverexpressionpancreastatinpeptide hormoneprohormoneresistance genetargeted treatmenttranscriptome sequencing
项目摘要
PROJECT SUMMARY
Chromogranin A (CgA) is a component of dense core vesicles of endocrine and neuroendocrine cells and
neurons that control the storage of neurotransmitters and hormones. CgA is a prohormone which is
processed into peptide hormones with distinct biological functions. Two of these peptides, catestatin (CST:
hCgA352-372) and pancreastatin (PST: hCgA250-301), exhibit diametrically opposite functions: CST is anti-
hypertensive, anti-inflammatory, and anti-diabetic, whereas PST is pro-inflammatory, pro-hypertensive and
pro-diabetic. High levels of CgA are present in the blood of patients with malignancies, inflammatory
diseases, and neurological disorders, and their levels rise as their clinical conditions worsen. Although Chga
(gene encoding CgA)-null mice have been available for nearly 20 years and have been widely studied, the
impact of CgA on aging has not been investigated. We found that CgA-KO mice develop hypertension at a
young age, but it reverses beyond the age of 12 months. We also noted that a few unused CgA-KO mice (all
male) that were kept aside lived at least 40 months. We also found that mRNA levels of lipoprotein lipase
(LPL), which controls triglyceride levels and V-set and immunoglobulin domain containing 4 (Vsig4), which
control bacterial clearance via autophagy, are low in the heart and liver of CgA-KO young mice but high in
old mice. We further found that leakage of bacterial DNA to other different organs in older WT mice. These
preliminary observations imply that CgA is an aging-inducing factor, but it has a positive role at early
ages through maintenance of lipid metabolism. We propose that differential processing of CgA into CST
and PST would determine aging through regulation of factors involved in metabolism and inflammation. This
proposal aims to investigate the validity of our hypothesis by assessing the lifespan, growth, mitochondrial
health, energy expenditure of a larger cohort of WT and CgA-KO males and females. We will further
determine the factors critical for CgA-induced aging and the pathways involved in the spontaneous reversal
of hypertension and lifespan extension of CgA-KO mice with emphasis on the lipoprotein-adipokine,
catecholamine-adrenergic receptor and Vsig-4-autophagy signaling axes in four different tissues.
The proposed research will be led by two Co-PIs: Dr. Mahata, a physiologist whose research focuses
on hypertension, insulin resistance and immunometabolism, and Dr. Ghosh, a biochemist who studies
inflammatory responses through the IKK-NF-B signaling pathways. If the hypotheses prove to be correct,
long-term studies to determine the underlying mechanisms of CgA-induced aging will be conducted.
Experiments proposed here will also help to determine if CgA can be targeted for therapy against
inflammatory disorders, aging-related and neurological disorders by lowering CgA transcripts at an older age
to reduce the pathogenic repercussions.
项目概要
嗜铬粒蛋白 A (CgA) 是内分泌和神经内分泌细胞致密核心囊泡的组成部分,
控制神经递质和激素储存的神经元 CgA 是一种激素原。
加工成具有不同生物功能的肽激素,其中两种肽是儿茶素(CST:)。
hCgA352-372) 和胰酶 (PST: hCgA250-301),表现出截然相反的功能:CST 是抗-
高血压、抗炎和抗糖尿病,而 PST 则促炎、促高血压和
恶性肿瘤、炎症患者的血液中存在高水平的 CgA。
疾病和神经系统疾病,其水平随着临床状况恶化而升高。
(基因编码CgA)缺失小鼠问世已近20年,并已得到广泛研究,
我们尚未研究 CgA 对衰老的影响。我们发现 CgA-KO 小鼠在一定时间内会出现高血压。
年轻时,但超过 12 个月后,我们还注意到一些未使用的 CgA-KO 小鼠(全部)。
男性)被放在一边至少活了 40 个月,我们还发现脂蛋白脂肪酶的 mRNA 水平。
(LPL),控制甘油三酯水平,V-set 和含有 4 (Vsig4) 的免疫球蛋白结构域,
通过自噬控制细菌清除,在 CgA-KO 幼鼠的心脏和肝脏中含量较低,但在 CgA-KO 幼鼠的心脏和肝脏中含量较高
我们进一步发现老年 WT 小鼠的细菌 DNA 渗漏到其他不同的器官。
初步观察表明CgA是一种诱发衰老的因素,但它对早期衰老有积极作用。
我们建议将 CgA 差异加工成 CST。
PST 会通过调节参与代谢和炎症的因素来决定衰老。
该提案旨在通过评估寿命、生长、线粒体来调查我们假设的有效性
我们将进一步研究更多 WT 和 CgA-KO 男性和女性群体的健康、能量消耗。
确定 CgA 诱导衰老的关键因素以及参与自发逆转的途径
高血压和 CgA-KO 小鼠寿命延长,重点是脂蛋白脂肪因子,
四种不同组织中的儿茶酚胺肾上腺素受体和 Vsig-4 自噬信号轴。
拟议的研究将由两位联合 PI 领导: Mahata 博士,一位生理学家,其研究重点是
高血压、胰岛素抵抗和免疫代谢方面的研究,以及生物化学家 Ghosh 博士的研究
如果假设被证明是正确的,
将进行长期研究以确定 CgA 诱导衰老的潜在机制。
这里提出的实验也将有助于确定 CgA 是否可以作为治疗的目标
通过在老年时降低 CgA 转录本来治疗炎症性疾病、衰老相关疾病和神经系统疾病
以减少致病影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GOURISANKAR GHOSH其他文献
GOURISANKAR GHOSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GOURISANKAR GHOSH', 18)}}的其他基金
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10446098 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Suppressing Inflammation by Blocking IKK Oligomer
通过阻断 IKK 寡聚物抑制炎症
- 批准号:
10573218 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
8067860 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
Cofactor-Mediated DNA Binding by the NF-kappaB Dimers
NF-kappaB 二聚体辅助因子介导的 DNA 结合
- 批准号:
10593119 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
Investigation of Gene Regulation by NF-kappaB Transcription factors
NF-kappaB 转录因子基因调控的研究
- 批准号:
7883453 - 财政年份:2009
- 资助金额:
$ 22.97万 - 项目类别:
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
苯乙酰谷氨酰胺通过beta-2肾上腺素能受体调节小胶质细胞活化参与糖尿病视网膜病变炎症的机制研究
- 批准号:82171071
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
- 批准号:
10663603 - 财政年份:2023
- 资助金额:
$ 22.97万 - 项目类别:
Deciphering age-dependent beige adipocyte failure
解读年龄依赖性米色脂肪细胞衰竭
- 批准号:
10589822 - 财政年份:2022
- 资助金额:
$ 22.97万 - 项目类别:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
- 批准号:
10553649 - 财政年份:2021
- 资助金额:
$ 22.97万 - 项目类别:
Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women
抗阻训练对肥胖绝经后妇女脂肪代谢的调节
- 批准号:
10211863 - 财政年份:2021
- 资助金额:
$ 22.97万 - 项目类别: